TY  - JOUR
AU  - Bueno Muiño, Coralia
AU  - Martín, Miguel
AU  - Monte Millán, María del
AU  - García Sáenz, José Ángel
AU  - López Tarruella Cobo, Sara
PY  - 2022
DO  - 10.3390/cancers14030512
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/71619
T2  - Cancers
AB  - Classical clinical research has been developed according to immunohistochemical breast cancer subtypes, instead of designing trials specifically for each molecular subtype. Efforts in de-escalating treatment should focus on identifying a subgroup of...
LA  - eng
M2  - 512
PB  - MPDI
KW  - Early
KW  - HER2+
KW  - Escalation
KW  - De-escalation
KW  - Intrinsic subtype
KW  - HER2-enriched
TI  - HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping
TY  - journal article
VL  - 14
ER  -